| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2015 | A randomized Phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib maintenance (PC/G) with gefitinib monotherapy (G) in East Asian patients (pts) with locally advanced or metastatic nonsquamous non-small cell lung cancer (nSqNSCLC): Final survival results. | Yang, James Chih-Hsin; Srimuninnimit, Vichien; Ahn, Myung-Ju; Lin, Chia-Chi; Kim, Sang-We; Tsai, Chun-Ming; Mok, Tony; Orlando, Mauro; Puri, Tarun; Wang, Xin; Park, Keunchil | J. Clin. Oncol. | | | |
| 2014 | Bcl-2-Like Protein 11 Deletion Polymorphism Predicts Survival in Advanced Non-Small-Cell Lung Cancer | Lee, Jih-Hsiang; Lin, Yu-Lin; Hsu, Wei-Hsun; Chen, Hsuan-Yu; Chang, Yeun-Chung; Yu, Chong-Jen; Shih, Jin-Yuan; Lin, Chia-Chi; Chen, Kuan-Yu; Ho, Chao-Chi; Laio, Wei-Yu; Yang, Pan-Chyr; Yang, James Chih-Hsin | J. Thorac. Oncol. | | | |
| 2014 | Bcl-2-Like Protein 11 Deletion Polymorphism Predicts Survival in Advanced Non-Small-Cell Lung Cancer | Lee, Jih-Hsiang; Lin, Yu-Lin; Hsu, Wei-Hsun; Chen, Hsuan-Yu; Chang, Yeun-Chung; Yu, Chong-Jen; Shih, Jin-Yuan; Lin, Chia-Chi; Chen, Kuan-Yu; Ho, Chao-Chi; Laio, Wei-Yu; Yang, Pan-Chyr; Yang, James Chih-Hsin; 楊泮池 | J. Thorac. Oncol. | | | |
| 2013 | Case report | Lin, Chia-Chi; JANN-YUAN WANG; Wang, Jann-Yuan; YEONG-SHIAU PU ; Pu, Yeong-Shiau | Journal of Clinical Oncology | 6 | 7 |  |
| 2016 | Comparison of skin toxic effects associated with gefitinib, erlotinib, or afatinib treatment for non-small cell lung cancer | Yi-Shuan Sheen; Chen, Kai-Lung; CHIA-YU CHU; Lin, Chia-Chi; Cho, Yung-Tsu; Yang, Che-Wen; Tsai, Hsiao-En; Chu, Chia-Yu | JAMA Dermatology | 17 | 15 | |
| 2006 | Differential Expression of Molecular Markers in Arsenic and Non-arsenic-related Urothelial Cancer | Hour, Tzyh-Chyuan; Pu, Yeong-Shiau; Lin, Chia-Chi; Huang, Shi-Wei; Chen, Jun; Chiu, Allen W.; Chen, Chien-Jen; Huang, Chao-Yuan | Anticancer Research | | | |
| 2008 | Down-Regulated Expression of Rhoa in Human Conventional Renal Cell Carcinoma | PU, YEONG-SHIAU; WANG, CHUANG-WEI; LIU, GUANG-YAW; KUO, YI-ZIH; HUANG, CHAO-YUAN; SHUN, CHIA-TUNG; LIN, CHIA-CHI; WU, WEN-JENG; HOUR, TZYH-CHYUAN | ANTICANCER RESEARCH | | | |
| 2008 | Down-Regulated Expression of RhoA in Human Conventional Renal Cell Carcinoma | Pu, Yeong-Shiau; Wang, Chuang-Wei; Liu, Guang-Yaw; Kuo, Yi-Zih; Huang, Chao-Yuan; Kang, Wang-Yi; Shun, Chia-Tung; Lin, Chia-Chi; Wu, Wen-Jeng; Hour, Tzyh-Chyuan | ANTICANCER RESEARCH | | | |
| 2013 | EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancer | Kao, Hsiang-Fong; Lin, Chia-Chi; Yang, James Chih-Hsin | Future Oncology | 7 | 6 | |
| 2006 | Epidermal Growth Factor Receptor Inhibitor (Pd168393) Potentiates Cytotoxic Effects of Paclitaxel against Androgen-Independent Prostate Cancer Cells | PU, YEONG-SHIAU; HSIEH, MIN-WEI; WANG, CHUANG-WEI; LIU, GUANG-YAW; HUANG, CHAO-YUAN; LIN, CHIA-CHI; GUAN, JING-YI; LIN, SHINNE- REN; HOUR, TZYH-CHYUAN; 蒲永孝; 謝旻娓; 王壯維; 劉光耀; 黃昭淵; 林家齊; 官靜儀; 林信仁; 侯自銓 | BIOCHEMICAL PHARMACOLOGY | | | |
| 2006 | Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells | Pu, Yeong-Shiau; Hsieh, Min-Wei; Wang, Chuang-Wei; Liu, Guang-Yaw; Huang, Chao-Yuan; Lin, Chia-Chi; Guan, Jing-Yi; Lin, Shinne-Ren; Hour, Tzyh-Chyuan | Biochemical Pharmacology | | | |
| 2015 | Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis | Chong-Jen Yu; Liao, Bin-Chi; Liao, Bin-Chi ; YA-FANG CHEN; Lee, Jih-Hsiang; Lee, Jih-Hsiang; CHAO-CHI HO; Lin, Chia-Chi; Lin, Chia-Chi; Chen, Ya-Fang; JIN-YUAN SHIH; Chen, Ya-Fang; Chang, Chin-Hao; Ho, Chao-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Shih, Jin-Yuan; Yu, Chong-Jen; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, James Chih-Hsin | Journal of Thoracic Oncology | 64 | 62 | |
| 2015 | Epidermal growth factor receptor tyrosine kinase inhibitors on clinical outcome of advanced non-small cell lung cancer patients with leptomeningeal carcinomatosis. | Liao, Bin-Chi; Lee, Jih-hsiang; Lin, Chia-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin | J. Clin. Oncol. | | | |
| 2015 | Epidermal growth factor receptor tyrosine kinase inhibitors on clinical outcome of advanced non-small cell lung cancer patients with leptomeningeal carcinomatosis. | Liao, Bin-Chi; Lee, Jih-hsiang; Lin, Chia-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin | J. Clin. Oncol. | | | |
| 2015 | Ipilimumab in treating Asian patient with advanced melanoma: The preliminary report of Taiwan ipilimumab extended access program group | Wu, Chun-Feng; Huang, Wen Kuan; Liu, Jun-Huang; Lin, Chen-Yuan; Liu, Ta-Chih; Lin, Chia-Chi; Su, Wu-Chou; Yeh, Yumin; Cheng, Shih-Tsung; Lin, Sheng-Fung; Hong, Ruey-Long; Chang, John W. C. | J. Clin. Oncol. | | | |
| 2015 | Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose | Venkatakrishnan, Karthik; Kim, Tae Min; Lin, Chia-Chi; Thye, Lim Soon; Chng, Wee Joo; Ma, Brigette; Chen, Ming Huang; Zhou, Xiaofei; Liu, Hua; Kelly, Virginia; Kim, Won Seog | Investigational New Drugs | 14 | 15 | |
| 2016 | Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumors | Minami, Hironobu; Ando, Yuichi; Ma, Brigette Buig Yue; Lee, Jih-Hsiang; Momota, Hiroyuki; Fujiwara, Yutaka; Li, Leung; Fukino, Koichi; Ito, Koji; Tajima, Takeshi; Mori, Asuka; Lin, Chia-Chi | Cancer Sci. | 12 | 13 | |
| 2007 | Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High-Dose 5-Fluorouracil and Leucovorin (TP-HDFL) for Metastatic Urothelial Carcinoma | Lin, Chia-Chi; Hsu, Chih-Hung | Journal of Urology | | | |
| 2015 | Postchemoradiotherapy (CRT) pathologic stage classified by American Joint Committee on Cancer (AJCC) staging system to predict prognosis of patients with locally advanced esophageal squamous cell carcinoma (ESCC) | Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Chang, Chin-Hao; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Journal of Clinical Oncology | 0 | 0 | |
| 2015 | Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma | MIN-SHU HSIEH; Guo, Jhe-Cyuan; Huang, Ta-Chen; JANG-MING LEE; ANN-LII CHENG ; Lin, Chia-Chi; PEI-MING HUANG; Hsieh, Min-Shu; Chang, Chin-Hao; Huang, Pei-Ming; Lee, Jang-Ming; Hsu, Feng-Ming; Cheng, Jason Chia-Hsien; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung | Journal of Thoracic Oncology | 6 | 7 | |
